scispace - formally typeset
Open AccessJournal ArticleDOI

SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing

TLDR
The regulation of SETD2 protein stability by the proteasome system and the identification of SPOP, a key subunit of the CUL3 ubiquitin E3 ligase complex, as a SETD 2-interacting protein are reported.
Abstract
Trimethylation of histone H3K36 is a chromatin mark associated with active gene expression, which has been implicated in coupling transcription with mRNA splicing and DNA damage response. SETD2 is a major H3K36 trimethyltransferase, which has been implicated as a tumor suppressor in mammals. Here, we report the regulation of SETD2 protein stability by the proteasome system, and the identification of SPOP, a key subunit of the CUL3 ubiquitin E3 ligase complex, as a SETD2-interacting protein. We demonstrate that SPOP is critically involved in SETD2 stability control and that the SPOP/CUL3 complex is responsible for SETD2 polyubiquitination both in vivo and in vitro ChIP-Seq analysis and biochemical experiments demonstrate that modulation of SPOP expression confers differential H3K36me3 on SETD2 target genes, and induce H3K36me3-coupled alternative splicing events. Together, these findings establish a functional connection between oncogenic SPOP and tumor suppressive SETD2 in the dynamic regulation of gene expression on chromatin.

read more

Citations
More filters

Conflict of interest statement. None declared.

TL;DR: It is found that women over 50 are more likely to have a family history of diabetes, especially if they are obese, than women under the age of 50.
Journal ArticleDOI

Writing, erasing and reading histone lysine methylations

TL;DR: A more detailed understanding of histone lysine methylation is necessary for elucidating complex biological processes and, ultimately, for developing and improving disease treatments.
Journal ArticleDOI

Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis

TL;DR: It is found that SETD2 counteracts Wnt signaling and its inactivation promotes intestinal tumorigenesis in mouse models of colorectal cancer (CRC) and ablation reduces intron retention of dishevelled segment polarity protein 2 (DVL2) pre-mRNA, thereby augmenting Wnt signalling.
Journal ArticleDOI

Shaping the cellular landscape with Set2/SETD2 methylation.

TL;DR: The latest insights into the functions of Set2/SETD2 in genome regulation and cancer development are summarized.
Journal ArticleDOI

Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly

TL;DR: SG assembly is aberrantly elevated in SPOP-mutated prostate cancer and the role of SPOP mutations in aberrant activation of the SG in prostate cancer is investigated and the relevanve of the mechanism in therapy resistance is explored.
References
More filters
Journal ArticleDOI

Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development.

TL;DR: The combined mutational frequency in ccRCC tumors of VHL and SETD2 suggests that there are still undiscovered tumor‐suppressor genes on 3p, and an important role for aberrant chromatin regulation inccRCC development.
Journal ArticleDOI

RNA polymerase II carboxyl-terminal domain phosphorylation regulates protein stability of the Set2 methyltransferase and histone H3 di- and trimethylation at lysine 36

TL;DR: It is found that Set2 has a short half-life and is co-regulated, with RNAPII CTD phosphorylation levels, during logarithmic growth in yeast and molecular insight is provided into the regulation of Set2 protein levels that influence H3K36 methylation states.
Journal ArticleDOI

Epigenetic regulation in RCC: opportunities for therapeutic intervention?

TL;DR: Data from RNA interference assays suggest that loss of function of PBRM1 drives proliferation and growth of ccRCC, but the clinical relevance of this is unclear and restoring the function of these genes for therapeutic purposes is likely to be challenging.
Related Papers (5)